These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 323834)

  • 41. Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.
    Alván G; Paintaud G; Eckernäs SA; Grahnén A
    Br J Clin Pharmacol; 1992 Jul; 34(1):47-52. PubMed ID: 1633067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bumetanide: potent new "loop" diuretic.
    Asbury MJ; Gatenby PB; O'Sullivan S; Bourke E
    Br Med J; 1972 Jan; 1(5794):211-3. PubMed ID: 4550872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of the interrelationship between dopaminergic activity and potassium ion.
    Matsuda S; Aoki N
    Clin Exp Hypertens A; 1984; 6(12):2249-61. PubMed ID: 6532601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RESPONSE OF THE INFANT KIDNEY TO DIURETIC DRUGS.
    WALKER RD; CUMMING GR
    Can Med Assoc J; 1964 Nov; 91(22):1149-53. PubMed ID: 14221781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Xipamid in the treatment of oedema in rheumatoid arthritis.
    Kalos A; Dixon AS; Weber JC
    Rheumatol Rehabil; 1974 May; 13(2):81-7. PubMed ID: 4602162
    [No Abstract]   [Full Text] [Related]  

  • 49. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure.
    Paterna S; Di Gaudio F; La Rocca V; Balistreri F; Greco M; Torres D; Lupo U; Rizzo G; di Pasquale P; Indelicato S; Cuttitta F; Butler J; Parrinello G
    Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of diuretic measures in hydropic condition. 3. Results in nephrotic syndrome, comparison with other disease groups].
    Praetorius F; Neuhaus GA; Horbach L; Michaelis J; Dürr F; Kaufmann W
    Klin Wochenschr; 1969 Nov; 47(21):1152-7. PubMed ID: 5382004
    [No Abstract]   [Full Text] [Related]  

  • 51. Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients.
    Bihari S; Holt AW; Prakash S; Bersten AD
    J Crit Care; 2016 Jun; 33():200-6. PubMed ID: 26948252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lasix.
    Med Lett Drugs Ther; 1967 Jan; 9(2):6-8. PubMed ID: 6032221
    [No Abstract]   [Full Text] [Related]  

  • 53. Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.
    Campra JL; Reynolds TB
    Am J Dig Dis; 1978 Nov; 23(11):1025-30. PubMed ID: 31086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of endogenous mineralocorticoids on the composition of fetal urine.
    Kairaitis K; Lumbers ER
    J Dev Physiol; 1990 Jun; 13(6):347-51. PubMed ID: 2084194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The combined diuretic action of quinethazone and furosemide in congestive heart failure. A permutation trial test.
    Olesen KH; Dupont B; Flensted-Jensen E
    Acta Med Scand; 1970; 187(1-2):33-40. PubMed ID: 4912468
    [No Abstract]   [Full Text] [Related]  

  • 56. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Acute effects of bumetanide in healthy subjects. A comparative study with furosemide (author's transl)].
    Ortź González A; Méndez Martin A
    Med Clin (Barc); 1979 Mar; 72(6):259-64. PubMed ID: 379471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary excretion of endogenous ouabain-like substance in furosemide-treated neonates: its relation to renal excretory pattern and endocrine factors.
    Sulyok E; Adamovits K; Worgall S; Rascher W
    Biol Neonate; 1997; 72(6):352-62. PubMed ID: 9428995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.